The Defense Production Act's Best-Kept Funding Door Closes September 30 — Inside the DPA Title III White-Paper Pathway

Most federal funding arrives through a named competition with a posted deadline: a solicitation drops, you apply by a date, reviewers score, awards go out. Title III of the Defense Production Act does not work that way, and that is precisely why so few companies that should use it ever do. It is one of the most flexible non-dilutive funding authorities in the federal government — capable of delivering direct payments, purchase commitments, loans, loan guarantees, and cost-shared production agreements to companies that expand or restore domestic production of defense-critical materials and technologies — and it runs through a white-paper-first pathway administered by the Air Force Research Laboratory's Materials and Manufacturing Directorate (AFRL/RX) under announcement FA8650-19-S-5010. There is no single deadline. There is a door you knock on, and a review process that decides whether to invite you in.

That door now has a clock on it. The core DPA authorities are set to sunset on September 30, 2026 absent congressional reauthorization, and the standing white-paper window itself has moved in and out of suspension as the program is administered against shifting priorities. For any company whose product sits in a defense-critical supply chain, that combination — enormous flexibility, an authority cliff, and an unconventional entry process — makes understanding the Title III mechanism unusually time-sensitive right now.

What Title III actually funds

Title III exists to strengthen national security by incentivizing domestic manufacturers to create, expand, or restore production capacity for critical technology items and industrial resources. The authority is deliberately broad. Where a typical grant funds a defined research project, Title III funds industrial capacity — the ability to make a thing, at scale, on American soil, that the defense supply chain cannot afford to source from abroad or cannot source domestically at all.

The tools available reflect that breadth. A Title III agreement can take the form of direct purchases, purchase commitments that guarantee a market, cost-shared production expansion, or loans and loan guarantees that de-risk a scale-up. This is fundamentally different from a research grant. Title III is not paying you to discover something; it is paying you to build the capacity to produce something the country has decided it needs domestically. AFRL's program is built to de-risk exactly that kind of production scale-up — the expensive, capital-intensive middle ground between a working prototype and a running production line, where private capital is often unwilling to go alone and where a supply chain gap becomes a national-security liability.

The priority areas track the broader federal industrial-base agenda: defense-critical materials, advanced manufacturing, and the components and processes that feed into weapons systems, electronics, and strategic supply chains. If your company makes something that a defense program depends on — and especially if the domestic supply of that thing is thin, concentrated, or foreign — you are in the conceptual center of what Title III was built to fund.

The white-paper pathway is the strategy

Because there is no conventional application, the entry mechanism is where companies succeed or fail. Title III uses a two-step, white-paper-first process: you submit a concise white paper describing the capability gap you would close and the production capacity you would build, and only upon favorable review are you invited to submit a full proposal. The white paper is the audition. Get it wrong and there is no full proposal to salvage; get it right and you enter a negotiated process toward an agreement.

This structure has three practical implications that reshape how you should approach it:

Lead with the vulnerability, not the technology. The single most common mistake companies make is writing a white paper about how impressive their product is. Title III does not fund impressive products; it funds closed supply-chain gaps. The white paper that gets invited forward opens with a specific, credible national-security vulnerability — a material the U.S. cannot produce domestically at needed volume, a component sourced from a single foreign supplier, a manufacturing capability that has atrophied — and then positions the company's production expansion as the fix. The technology matters only as the means to close the gap.

Speak the program's language of capacity. Reviewers are evaluating whether funding you meaningfully strengthens the domestic industrial base. That means quantifying capacity: what you can produce today, what you could produce with Title III support, the timeline to reach it, and how that new capacity maps to a documented defense need. Vague claims of "scaling up" lose to specific production numbers tied to a specific gap.

Treat the white paper as a screening bet, not a full proposal. Because it is short and the full proposal comes only on invitation, the white paper is a comparatively low-cost way to test whether AFRL sees strategic value in your capability. Companies that would never invest in a full grant application can afford to float a well-constructed white paper — and the ones that do are competing against a surprisingly thin field, because so few eligible manufacturers know the pathway exists.

The September 30 authority cliff changes the calculus

Layered on top of the mechanics is timing that a prospective applicant cannot ignore. The core DPA authorities sunset September 30, 2026 unless Congress reauthorizes them. Historically, Congress has repeatedly reauthorized the Defense Production Act — it is a foundational national-security tool dating to 1950 — but reauthorization has never been automatic, and the window between now and the sunset is a period of genuine uncertainty about how, and how aggressively, Title III money will flow. Separately, the standing AFRL white-paper vehicle has at points moved into suspension, meaning the practical availability of the entry pathway can shift with little notice.

For a company weighing Title III, the honest reading is this: the authority is live now, the appetite for domestic industrial-base investment is high, and the entry cost of a white paper is low — but the specific status of the FA8650-19-S-5010 window and the post-September authority landscape must be verified directly on grants.gov (or SAM.gov) before you invest, because both have proven changeable. The strategic move is not to wait for certainty that may not arrive; it is to prepare the supply-chain-vulnerability case now, so that whenever the window is confirmed open, you are ready to submit rather than starting from scratch against a closing authority.

How to position before the door narrows

Three concrete steps follow from all of this:

Document your supply-chain criticality in national-security terms. Before you write anything for AFRL, build the case that your capability closes a defense-relevant gap — ideally with reference to known shortfalls in critical materials, microelectronics, or advanced manufacturing. That case is the spine of every Title III engagement.

Quantify the capacity delta. Assemble the numbers: current production capacity, the capacity Title III support would unlock, the capital required, the timeline, and the cost-share you can bring. Title III agreements are negotiated around real production economics, and companies that arrive with those numbers already modeled move faster.

Verify the live window and authority status. Because both the white-paper window and the underlying DPA authority are in motion heading into the September 30 sunset, confirm current status on the official portals before committing resources — and if the window is open, do not wait, because a closing authority is not a deadline you can request an extension on.

The bigger picture

Title III is a preferred pathway for exactly the companies the current federal industrial-base push is trying to reach — domestic manufacturers of defense-critical materials and technologies whose products matter to national security supply chains. It is powerful, it is unconventional, and it is dramatically underused relative to its flexibility, largely because the white-paper pathway is invisible to companies conditioned to look for posted grant competitions. With the authority cliff approaching, the companies that understand the mechanism — and lead with a supply-chain vulnerability rather than a product pitch — have a rare, closing opportunity to access capital that behaves like almost nothing else in the federal system.

To track defense industrial-base and advanced-manufacturing funding across DoD, DOE, and beyond, the Granted grant database surfaces live opportunities matched to your technology, stage, and supply-chain role.